70 related articles for article (PubMed ID: 29593431)
1. Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation.
Wang K; Li Z; Chen X; Zhang J; Xiong Y; Zhong G; Shi Y; Li Q; Zhang X; Li H; Xiang T; Foukakis T; Radivoyevitch T; Ren G
NPJ Breast Cancer; 2021 Mar; 7(1):21. PubMed ID: 33654083
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ and cause-specific mortality among younger and older postmenopausal women: the Women's Health Initiative.
Pan K; Nelson RA; Chlebowski RT; Piela R; Mullooly M; Simon MS; Rohan TE; Wactawski-Wende J; Manson JE; Mortimer JE; Lane D; Kruper L
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38730133
[TBL] [Abstract][Full Text] [Related]
3. Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.
Almekinders MMM; Schaapveld M; Thijssen B; Visser LL; Bismeijer T; Sanders J; Isnaldi E; Hofland I; Mertz M; Wessels LFA; Broeks A; Hooijberg E; Zwart W; Lips EH; ; Desmedt C; Wesseling J
NPJ Breast Cancer; 2021 Mar; 7(1):31. PubMed ID: 33753731
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression.
Bachawal S; Bean GR; Krings G; Wilson KE
NPJ Breast Cancer; 2020; 6():14. PubMed ID: 32377564
[TBL] [Abstract][Full Text] [Related]
5. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.
Lopes Cardozo JMN; Andrulis IL; Bojesen SE; Dörk T; Eccles DM; Fasching PA; Hooning MJ; Keeman R; Nevanlinna H; Rutgers EJT; Easton DF; Hall P; Pharoah PDP; van 't Veer LJ; Schmidt MK;
J Clin Oncol; 2023 Apr; 41(10):1849-1863. PubMed ID: 36689693
[TBL] [Abstract][Full Text] [Related]
6. Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands.
Rajan KK; Nijveldt JJ; Verheijen S; Siesling S; Beek MA; Francken AB
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874687
[TBL] [Abstract][Full Text] [Related]
7. A medicare-based comparative mortality analysis of active surveillance in older women with DCIS.
Akushevich I; Yashkin AP; Greenup RA; Hwang ES
NPJ Breast Cancer; 2020; 6():57. PubMed ID: 33145400
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ (DCIS) presenting as a cystic retroareolar lesion in an African American man.
Ndumele A; Kerger A; Tozbikian G; Obeng-Gyasi S; Oppong BA
Clin Case Rep; 2021 Jun; 9(6):e04166. PubMed ID: 34194764
[TBL] [Abstract][Full Text] [Related]
9. Omission of Radiotherapy for Women With Low-Risk Invasive Cancers That Have a Ductal Carcinoma In Situ Component.
Sorscher S
J Clin Oncol; 2024 Jun; 42(16):1998. PubMed ID: 38489565
[No Abstract] [Full Text] [Related]
10. The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database.
Wang J; Zhang WW; Lian CL; Sun JY; He ZY; Wu SG
Front Oncol; 2019; 9():747. PubMed ID: 31475106
[No Abstract] [Full Text] [Related]
11. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
12. Tumor location of the central and nipple portion is associated with impaired survival for women with breast cancer.
Ji F; Xiao WK; Yang CQ; Yang M; Zhang LL; Gao HF; Lin YF; Zhu T; Cheng MY; Li WP; Pan WJ; Zhuang XS; Wang K
Cancer Manag Res; 2019; 11():2915-2925. PubMed ID: 31040717
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion.
Xia LY; Xu WY; Hu QL
Sci Rep; 2022 Nov; 12(1):20132. PubMed ID: 36418384
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of co-existence ductal carcinoma
Chen H; Bai F; Wang M; Zhang M; Zhang P; Wu K
Ann Transl Med; 2019 Sep; 7(18):484. PubMed ID: 31700920
[TBL] [Abstract][Full Text] [Related]
15. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.
Lee WP; Shetty SS; Seah CMJ; Tan PT; Tan SM
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1646. PubMed ID: 35892151
[TBL] [Abstract][Full Text] [Related]
16. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
17. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.
Pawloski KR; Tadros AB; Sevilimedu V; Newman A; Gentile L; Zabor EC; Morrow M; Van Zee KJ; Kirstein LJ
Breast Cancer Res Treat; 2021 Apr; 186(3):617-624. PubMed ID: 33675490
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
Wu SG; Zhang WW; Sun JY; He ZY
Cancer Manag Res; 2018; 10():527-534. PubMed ID: 29593431
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
